Covance's Clinical Pharmacology Business Receives Lilly's Global Supplier Award for the Second Consecutive Year
PRINCETON, N.J., May 27 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that its clinical pharmacology business received Lilly's 2009 Global Supplier Award for its commitment to helping Lilly meet its corporate objectives. This was the second consecutive year Covance was recognized for outstanding customer service for its clinical pharmacology services. The Lilly Global Supplier Award acknowledges those key suppliers who contribute the best in innovation and technology towards Lilly's success.
Covance was judged by a committee of Lilly representatives on criteria including delivery of exemplary quality, service, speed, total cost reduction, supplier relationship management, and supplier diversity.
"It's a true honor to be one of the dozen companies to win this award among Lilly's 6,500 global suppliers," said Covance Chief Operating Officer Wendel Barr. "Delivering exceptional customer service is always a first priority for Covance, and being recognized for doing so by one of the world's most prominent pharmaceutical companies, for two consecutive years, is a tremendous achievement."
Covance's clinical pharmacology service offering evaluates the safety and efficacy of potential new drugs in humans, including the conduct of first-in-human trials. Covance has pioneered many of the specialized services in its diversified portfolio of drug development services and that uniquely positions the company as a valued partner in helping to progress compounds from preclinical to proof-of-concept studies.
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in 25 countries, and more than 9,800 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.
|SOURCE Covance Inc.|
Copyright©2009 PR Newswire.
All rights reserved